DIVINE剂量选择模型在日常辅助生殖实践中的效果:活产率与安全性
该回顾性队列研究比较了荷兰两家生殖中心在实施DIVINE剂量计算器前后首次IVF/ICSI新鲜周期的结局。实施后活产率无显著差异(25.8% vs 24.0%,OR 0.96,95%CI 0.62-1.51),但卵巢过度刺激相关治疗风险从10.8%降至3.1%(OR 0.28,95%CI 0.10-0.78),OHSS发生率从6.4%降至0%。结论认为该工具在不影响疗效的前提下显著降低治疗风险。
要点
- DIVINE剂量计算器未降低首次新鲜IVF/ICSI周期的活产率。
- 实施后卵巢过度刺激相关治疗风险显著下降(OR 0.28)。
- 卵巢过度刺激综合征发生率从6.4%降至0%。
核心结论
- 实施DIVINE剂量计算器可显著降低卵巢过度刺激相关治疗风险,且不影响首次新鲜IVF/ICSI周期的活产率。
研究设计与样本
- 回顾性队列研究,比较荷兰两家生殖中心实施DIVINE剂量计算器前后的ART结局。
- 纳入601名年龄<39岁、首次开始IVF/ICSI周期的不孕女性,其中实施前组472例,实施后组129例。
- 剂量计算器基于女性年龄、抗苗勒管激素浓度和GnRH(拮抗)剂方案,选择100至225 IU的FSH起始剂量。
- 采用逆倾向权重平衡潜在混杂因素,并使用广义线性模型或有序逻辑回归模型进行加权回归。
主要发现
- 实施剂量计算器前后,每新鲜周期活产率分别为25.8%和24.0%(OR 0.96,95%CI 0.62-1.51)。
- 卵巢过度刺激相关治疗风险从实施前的10.8%降至实施后的3.1%(OR 0.28,95%CI 0.10-0.78)。
- 卵巢过度刺激综合征发生率从实施前的6.4%降至实施后的0%。
临床怎么用
- 在首次IVF/ICSI周期中可考虑使用DIVINE剂量计算器选择FSH起始剂量,以降低卵巢过度刺激风险而不影响活产率。
局限性
- 本研究为回顾性队列研究,样本量有限(实施后组仅129例),可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does implementation of the DIVINE dose calculator in routine care reduce treatment risk due to ovarian hyperstimulation whilst maintaining treatment efficacy? DESIGN: A retrospective cohort study comparing assisted reproductive technology outcomes from women treated before and after implementation of the DIVINE dose calculator. Data were collected from two Dutch fertility centres. The dose calculator included female age, anti-Müllerian hormone concentration, and gonadotrophin-releasing hormone-(ant)agonist protocol to select the most appropriate starting dose of FSH between 100 and 225 IU. Baseline characteristics of subfertile women aged <39 years starting their first IVF/intracytoplasmic sperm injection (ICSI) treatment cycle, and fresh cycle treatment outcomes were collected. Inverse propensity weighting was applied to balance potential confounders. Weighted regression was performed using general linear models or ordered logistic regression models, according to the outcome variable. The primary outcome variables were live birth rate and safety risk. RESULTS: Data were obtained for 601 women: 472 in the pre-dose calculator group and 129 in the post-dose calculator group. There was no difference in the live birth rate per fresh cycle before and after implementation of the dose calculator: 25.8% versus 24.0% respectively (OR 0.96, 95% CI 0.62-1.51). The treatment risk due to ovarian hyperstimulation decreased after implementation of the dose calculator from 10.8% in the pre-dose calculator period to 3.1% in the post-dose calculator period (OR 0.28, 95% CI 0.10-0.78), and the incidence of ovarian hyperstimulation syndrome decreased from 6.4% to 0% after implementation of the dose calculator. CONCLUSION: Implementation of the DIVINE dose calculator significantly reduces treatment risks caused by ovarian hyperstimulation, without affecting treatment efficacy in terms of the live birth rate in first fresh IVF/ICSI cycles.
引用
- Schouten NE, van Tilborg TC, Cianci D, et al. The DIVINE dose-selection model in daily ART practice: effects on live birth rate and safety. Reprod Biomed Online. 2026. PMID: 42033979. doi:10.1016/j.rbmo.2026.105496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。